TickerFacts.

Company research / BGM

BGM Group Ltd. (BGM)

Build a valuation ↗↓ Download CSV

CIK 0001779578 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Sep 30

For the year ended 2025-09-30, BGM Group Ltd. reported revenue of $37.92M. Revenue grew 51.1% from the prior annual period.

Key ratios (year ended 2025-09-30)

16.6%
Gross margin
-33.2%
Operating margin
-52.6%
Net margin
-5.1%
Return on year-end equity
51.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-09-24

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Stock splits: 1-for-5, first reflected in a filing dated 2025-01-27. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period ended2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-30
Revenue$37.92M$25.10M$46.47M$64.86M$57.10M$50.03M$46.10M$50.37M
Cost of Revenue$31.61M$20.98M$44.72M$58.63M$51.46M$42.49M$36.42M$42.24M
Gross Profit$6.31M$4.11M$1.75M$6.23M$5.64M$7.54M$9.68M$8.13M
R&D Expense$672.7K$1.36M$568.5K$1.22M$8.0K$54.0K$44.0Kn/a
Operating Income-$12.58M-$563.8K-$2.61M$2.10M$2.39M$4.81M$6.18M$5.97M
Depreciation & Amortization$1.46M$1.24M$1.14M$1.22M$1.20M$1.11M$1.19M$1.25M
EBITDA-$11.12M$673.5K-$1.47M$3.33M$3.59M$5.92M$7.37M$7.23M
Net Income-$19.94M-$1.44M-$7.78M$1.08M$3.15M$5.06M$5.91M$5.20M
EPS (Diluted)-$0.18-$0.20-$1.08$0.15$0.09$0.17$0.18n/a
Total Assets$433.81M$53.00M$51.26M$64.53M$75.35M$48.14M$35.27Mn/a
Total Liabilities$41.92M$8.91M$6.91M$9.56M$18.68M$19.30M$12.63Mn/a
Shareholders' Equity$391.90M$44.09M$44.35M$54.96M$56.67M$28.84M$22.64M$17.72M
Cash & Equivalents$9.82M$9.82M$7.48M$14.32M$10.47M$11.87M$4.59Mn/a
Operating Cash Flow-$2.37M$544.2K$312.2K$12.65M$345.0K$5.08M-$580.2K$4.44M
Capital Expenditures$1.57M$240.1K$179.8K$2.03M$1.49M$449.8K$616.4K$1.12M
Free Cash Flow-$3.94M$304.1K$132.4K$10.62M-$1.15M$4.63M-$1.20M$3.32M
Dividends Paidn/an/a$1.79Mn/an/an/an/an/a
Shares Outstanding200.62M7.23M7.23M7.23M35.75M30.00M30.00Mn/a
Weighted Average Diluted Shares113.26M7.23M7.23M7.23M34.09M30.00M30.00Mn/a
EPS (Basic)-$0.18-$0.20-$1.08$0.15$0.09$0.17$0.18n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView